Phase II Study of RC-160 (Vapreotide), an Octapeptide Analogue of Somatostatin, in the Treatment of Metastatic Breast Cancer
British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6690226
Full Text
Open PDFAbstract
Available in full text
Date
February 26, 1999
Authors
Publisher
Springer Science and Business Media LLC